Asia · Regional markets · Yicai Global

Germany's Drug Price Reform Brings New Opportunities and Challenges to Chinese Drugmakers as Global Peers Reassess Investment

Published by Yicai Global · China 15 h ago

Roche has temporarily put all future investment decisions in Germany on hold due to local healthcare cost-cutting policies, Daniel Steiner, chief executive of the Swiss…

Read the full article on Yicai Global Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.yicaiglobal.com)

Also worth reading

The Straits Times Business

Google’s AI bet bites back in record US$500b market wipeout

CNBC-TV18

MTAR Technologies Q2 profit jumps 14-fold to ₹60 crore as revenue triples

Mint

Coal India dividend 2026 declared - Check amount; PSU quarterly profit up 57% - When is record date?

Tech in Asia

DoorDash to buy Instacart in US$17b deal

The Business Times

Jio’s blockbuster debut puts valuation, earnings in focus

Pulse (Maeil Business)